Posts by holly

20-22 September 2017 – Nonacus to Attend CNAPS 2017

Nonacus is attending and sponsoring the 10th CNAPS International Symposium in Montpellier. Dr Michael Parks’ abstract has been accepted for an oral presentation: A direct from plasma approach to non-invasive prenatal fetal sex determination and RhesusD genotyping by quantitative PCR
Read More

27–30 May 2017 – Nonacus ESHG 2017 Abstract Accepted

Dr Michael Parks, previous recipient of the ESHG young investigator award, will be presenting a poster on our innovative Plasma Cell3TMDirect qPCR technology at the ESHG 2017 conference in Copenhagen:‘A direct from plasma approach to non-invasive prenatal fetal sex determination and RhesusD genotyping by quantitative PCR’(Control No. 2017-A-719-ESHG).
Read More

6-7th April – cfDNA 2017 Copenhagen

Nonacus is attending and sponsoring the 3rd International Meeting on Cell Free DNA conference in Copenhagen. Come and visit the team at booth H. Dr Michael Parks will be presenting our technology at the conference : A direct from plasma approach for non-invasive fetal RhesusD genotyping April 06, 2017, 16:10-16:45.
Read More

1st July 2016 – Nonacus Open R&D Laboratory at the BioHub Birmingham

We are pleased to announce that we have moved into our new business premises and laboratory at the Birmingham BioHub. The facility offers purpose built state of the art laboratory and office space. The team are looking forward to getting to work and making the most of the new facilities.
Read More

24th March 2016 – Nonacus Successfully Closes First Round of Investment Funding

We are pleased to announce that we have successfully closed our first round of investment funding from private investors who share our vision of developing high quality, clinically focussed, consumable products that enable clinicians and their staff to take advantage of the accessibility and information now available from cell free DNA.
Read More